SCHEMBL358161

SCHEMBL358161

CCCCCCC=CCCCCCCCC(=O)OCC

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.73
CYP3A4 P08684 2/20 0.73
ALOX15 P16050 2/20 0.73
ALDH1A1 P00352 1/20 0.73
TSHR P16473 1/20 0.73
TDP1 Q9NUW8 1/20 0.73
FAAH O00519 4/20 0.70
DGKA P23743 1/20 0.65
PGR P06401 2/20 0.62
ADORA3 P0DMS8 2/20 0.62
NR1I2 O75469 1/20 0.62
PTGS2 P35354 1/20 0.62
PDE4D Q08499 1/20 0.62
PRKCE Q02156 1/20 0.61
PRKCQ Q04759 1/20 0.61
PRKCD Q05655 1/20 0.61
PRKCA P17252 1/20 0.61
TERT O14746 3/20 0.61
CYP1A2 P05177 2/20 0.61
MAPT P10636 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10481167 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
Ethyl Oleate SCHEMBL874561 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
SCHEMBL8982640 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
Ethyl Oleate SCHEMBL16163583 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
SCHEMBL8982772 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
SCHEMBL7557821 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
SCHEMBL25490302 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
SCHEMBL8982687 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
Ethyl Oleate SCHEMBL14763720 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR
SCHEMBL10084979 1.00 HSD17B10 (0.73) HSD17B10CYP3A4ALOX15ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 444 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028562-A1 FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION DANSTAR FERMENT AG (CH) 2026-01-29 US claimed
EP-4557970-A1 FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION Danstar Ferment AG (CH) 2025-05-28 EP claimed
EP-4493683-A1 ACYL-ACP THIOESTERASE VARIANTS AND USES THEREOF Genomatica, Inc. (US) 2025-01-22 EP claimed
CN-119286673-A Bacillus amyloliquefaciens for improving soy sauce color, inhibiting bacteria and enhancing aroma and application thereof 天津科技大学 2025-01-10 CN claimed
CN-117925426-A Rhodotorula mucilaginosa (Rhodotorula mucilaginosa) strain 147 and application, product and method thereof 宁夏农产品质量标准与检测技术研究所(宁夏农产品质量监测中心) 2024-04-26 CN claimed
CN-117801970-A Hansenula polymorpha (Hanseniaspora uvarum) strain 181 with grape juice, application, product and method thereof 宁夏农产品质量标准与检测技术研究所(宁夏农产品质量监测中心) 2024-04-02 CN claimed
CN-117801959-A Naganishia globosa strain 212 and application, product and method thereof 宁夏农产品质量标准与检测技术研究所(宁夏农产品质量监测中心) 2024-04-02 CN claimed
CN-117778209-A Saccharomyces cerevisiae (Clavispora lusitaniae) strain 115 and application, product and method thereof 宁夏农产品质量标准与检测技术研究所(宁夏农产品质量监测中心) 2024-03-29 CN claimed
CN-117778211-A Fisher-b-schiff yeast (Cyberlindnera fabianii) strain 20, application, product and method thereof 宁夏农产品质量标准与检测技术研究所(宁夏农产品质量监测中心) 2024-03-29 CN claimed
CN-117778210-A Candida glabrata strain 196 and application, product and method thereof 宁夏农产品质量标准与检测技术研究所(宁夏农产品质量监测中心) 2024-03-29 CN claimed
EP-2493508-A2 TRANSDERMAL PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE AGENTS Besins Healthcare Luxembourg SARL (LU) 2012-09-05 EP claimed
US-8258330-B1 Carrier fluid composition comprising fatty acids ethyl esters and process for reducing the concentration of persistent organic pollutants in fish oil Naturalis, S.A. (CL) 2012-09-04 US claimed
US-8110670-B2 Enhanced production of fatty acid derivatives LS9, INC. (US) 2012-02-07 US claimed
WO-2011051354-A2 TRANSDERMAL PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE AGENTS BESINS HEALTHCARE LUXEMBOURG SARL (LU) 2011-05-05 WO claimed
US-20110098258-A1 Transdermal Pharmaceutical Compositions Comprising Active Agents BESINS HEALTHCARE LUXEMBOURG 2011-04-28 US claimed
US-20100251601-A1 ENHANCED PRODUCTION OF FATTY ACID DERIVATIVES LS9, INC. (US) 2010-10-07 US claimed
EP-2129785-A2 ENHANCED PRODUCTION OF FATTY ACID DERIVATIVES Ls9, Inc. (US) 2009-12-09 EP claimed
WO-2008119082-A2 ENHANCED PRODUCTION OF FATTY ACID DERIVATIVES LS9, INC. (US) 2008-10-02 WO claimed
CN-1751601-A Low cholesterol eggs rich in conjugate linoleic acid, and its prodn. method NO 1 OCEANOLOGY RES INST OF ST (CN) 2006-03-29 CN claimed
US-4820513-A LINALOOL AND UPWARD FLIGHT STIMULANT UNIVERSITY OF SOUTHAMPTON (GB) 1989-04-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028562-A1 FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION CD69, SORD, TAS2R13 HSD17B10 1085/4885CYP3A4 1977/4885ALOX15 3494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.